JP2021517587A - 腫瘍浸潤リンパ球(tils)を活性化する方法 - Google Patents
腫瘍浸潤リンパ球(tils)を活性化する方法 Download PDFInfo
- Publication number
- JP2021517587A JP2021517587A JP2020557373A JP2020557373A JP2021517587A JP 2021517587 A JP2021517587 A JP 2021517587A JP 2020557373 A JP2020557373 A JP 2020557373A JP 2020557373 A JP2020557373 A JP 2020557373A JP 2021517587 A JP2021517587 A JP 2021517587A
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- cancer
- til
- subject
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024000217A JP2024050573A (ja) | 2018-01-09 | 2024-01-04 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862615300P | 2018-01-09 | 2018-01-09 | |
| US62/615,300 | 2018-01-09 | ||
| PCT/CN2019/070944 WO2019137384A1 (en) | 2018-01-09 | 2019-01-09 | Method of activating tumor-infiltrating lymphocytes (tils) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000217A Division JP2024050573A (ja) | 2018-01-09 | 2024-01-04 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021517587A true JP2021517587A (ja) | 2021-07-26 |
| JP2021517587A5 JP2021517587A5 (cg-RX-API-DMAC7.html) | 2022-01-11 |
Family
ID=67139037
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020557373A Pending JP2021517587A (ja) | 2018-01-09 | 2019-01-09 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
| JP2024000217A Pending JP2024050573A (ja) | 2018-01-09 | 2024-01-04 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000217A Pending JP2024050573A (ja) | 2018-01-09 | 2024-01-04 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11179425B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3737395A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2021517587A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111655272A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI817977B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019137384A1 (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2019240218A1 (ja) * | 2018-06-14 | 2021-07-01 | 株式会社明治 | 免疫チェックポイント阻害療法を促進するための組成物 |
| WO2024057892A1 (ja) | 2022-09-12 | 2024-03-21 | 賢一郎 蓮見 | 抗腫瘍免疫応答増強剤 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003026582A (ja) * | 2001-03-21 | 2003-01-29 | Microbio Co Ltd | 癌の抑制、感染症の低下、および健康の促進に用いる組成物 |
| WO2017167213A1 (en) * | 2016-03-30 | 2017-10-05 | Microbio Co., Ltd. | Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60134386D1 (de) | 2001-03-21 | 2008-07-24 | Microbio Co Ltd | Verfahren zur Hemmung von Krebswachstum mit einem fermentierten Soja- Extrakt |
| JP2003335695A (ja) * | 2002-05-17 | 2003-11-25 | Nippon Bio Kk | 大豆発酵物よりなる免疫増強剤、抗腫瘍剤、加工食品および大豆発酵物の製造方法 |
| TWI252759B (en) | 2002-07-05 | 2006-04-11 | Microbio Co Ltd | Method of using fermented glycine max (L.) extract for enhancing natural killer cell activity |
| CN100352459C (zh) | 2004-07-15 | 2007-12-05 | 中天生物科技股份有限公司 | 发酵大豆萃取液在制备药物中的应用 |
| SG187554A1 (en) | 2010-07-20 | 2013-03-28 | Microbio Co Ltd | Use of a fermented soy extract for manufacture of a prebiotic composition |
| EP2659898B1 (en) * | 2010-12-28 | 2018-03-07 | Kirin Holdings Kabushiki Kaisha | Use of lactococcus bacteria in the treatment or prevention of viral infections |
| JP2015051970A (ja) | 2013-09-06 | 2015-03-19 | マイクロバイオ カンパニー, リミテッド | 化学療法を受けているがん患者向けのアジュバントを製造するための組成物 |
| EA201690912A1 (ru) * | 2013-11-05 | 2016-10-31 | Когнейт Биосервисис, Инк. | Комбинации ингибиторов контрольных точек и терапевтических средств для лечения рака |
| EP3228701A1 (en) * | 2016-04-05 | 2017-10-11 | Fundación Centro Nacional de Investigaciones Oncológicas Carlos III | Method for preparing lymphocytes capable of infiltrating a solid tumor, lymphocytes obtainable by said method and uses thereof |
| CN112779217B (zh) * | 2021-03-29 | 2023-04-11 | 复旦大学附属中山医院 | 一种高记忆表型肿瘤浸润t淋巴细胞的培养方法 |
-
2019
- 2019-01-09 TW TW108100871A patent/TWI817977B/zh active
- 2019-01-09 EP EP19738681.6A patent/EP3737395A4/en not_active Ceased
- 2019-01-09 US US16/243,325 patent/US11179425B2/en active Active
- 2019-01-09 WO PCT/CN2019/070944 patent/WO2019137384A1/en not_active Ceased
- 2019-01-09 EP EP25218977.4A patent/EP4755455A2/en active Pending
- 2019-01-09 JP JP2020557373A patent/JP2021517587A/ja active Pending
- 2019-01-09 CN CN201980007599.2A patent/CN111655272A/zh active Pending
-
2024
- 2024-01-04 JP JP2024000217A patent/JP2024050573A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003026582A (ja) * | 2001-03-21 | 2003-01-29 | Microbio Co Ltd | 癌の抑制、感染症の低下、および健康の促進に用いる組成物 |
| WO2017167213A1 (en) * | 2016-03-30 | 2017-10-05 | Microbio Co., Ltd. | Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota |
Non-Patent Citations (1)
| Title |
|---|
| SIVAN, A. ET AL.: "Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy", SCIENCE, vol. 350, no. 6264, JPN6022051734, 2015, pages 1084 - 1089, ISSN: 0004937805 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2019240218A1 (ja) * | 2018-06-14 | 2021-07-01 | 株式会社明治 | 免疫チェックポイント阻害療法を促進するための組成物 |
| US11759485B2 (en) | 2018-06-14 | 2023-09-19 | Meiji Co., Ltd. | Composition for enhancing immune checkpoint blockade therapy |
| JP7490554B2 (ja) | 2018-06-14 | 2024-05-27 | 株式会社明治 | 免疫チェックポイント阻害療法を促進するための組成物 |
| WO2024057892A1 (ja) | 2022-09-12 | 2024-03-21 | 賢一郎 蓮見 | 抗腫瘍免疫応答増強剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3737395A4 (en) | 2021-09-29 |
| US11179425B2 (en) | 2021-11-23 |
| TW201938181A (zh) | 2019-10-01 |
| CN111655272A (zh) | 2020-09-11 |
| EP4755455A2 (en) | 2026-06-10 |
| TWI817977B (zh) | 2023-10-11 |
| EP3737395A1 (en) | 2020-11-18 |
| US20190209623A1 (en) | 2019-07-11 |
| JP2024050573A (ja) | 2024-04-10 |
| WO2019137384A1 (en) | 2019-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI791111B (zh) | 具有預防或治療癌症的效果的新穎菌株 | |
| JP7594826B2 (ja) | ラクトバチルス・プランタルムgb104株及びそれを含むがんの予防又は処置のための組成物 | |
| US12186350B2 (en) | Antitumor effect potentiator | |
| Marinelli et al. | Probiotic species in the modulation of the anticancer immune response | |
| EP3444332A1 (en) | Medium addition kit for culturing nk cells and nk cell culturing method using kit | |
| CN109966320B (zh) | 凝结芽孢杆菌在制备诱导抗肿瘤免疫及免疫检查点抑制剂增敏制剂中的应用 | |
| CN106148282B (zh) | 一种自然杀伤细胞的培养方法 | |
| CN109771445B (zh) | 酪酸梭菌在制备诱导抗肿瘤免疫及免疫检查点抑制剂增敏制剂中的应用 | |
| JP2024050573A (ja) | 腫瘍浸潤リンパ球(tils)を活性化する方法 | |
| CN112334141B (zh) | 用于促进免疫检查点抑制疗法的组合物 | |
| CN116421630A (zh) | 一种防治肿瘤的嗜粘蛋白阿克曼氏菌产品及其应用 | |
| JP7628958B2 (ja) | T細胞機能を向上させるための組成物及び方法 | |
| CN115806893B (zh) | 普通拟杆菌及其组合物在辅助癌症免疫治疗中的应用 | |
| CN117503802A (zh) | Ac菌在抗肿瘤免疫治疗中的应用 | |
| KR102881730B1 (ko) | 항암 활성을 갖는 신규 박테리아 균주 및 이를 이용한 암의 완화, 예방 또는 치료용 조성물 | |
| TWI847370B (zh) | 用以預防或治療癌症或發炎的包含新穎腸膜明串珠菌菌株之組成物及使用其預防或治療癌症或發炎的方法 | |
| TWI847369B (zh) | 新穎腸膜明串珠菌菌株 | |
| JP6088648B2 (ja) | 貪食細胞へ物質を送達する担体 | |
| JP4308350B2 (ja) | シイタケ菌糸体抽出物を含有するlak活性スクリーニング物質およびそれを用いたlak活性スクリーニング法 | |
| EP4591872A1 (en) | Composition comprising lactobacillus plantarum strain for improving intestinal metabolite composition | |
| KR20230121536A (ko) | 락토바실러스 플란타룸 균주 및 항암제를 포함하는 병용 요법을 이용한 암 예방 또는 치료용 조성물 | |
| JP2025529567A (ja) | ラクトバチルス・プランタルム菌株を含む腸内代謝産物組成を改善するための組成物 | |
| JP5761679B2 (ja) | パパイア発酵物を有効成分とする末梢血単核球細胞の活性調節用組成物 | |
| KR20240123764A (ko) | 락토바실러스 플란타룸 균주 및 면역세포의 병용 요법을 이용한 암 예방 또는 치료용 조성물 | |
| KR20240040601A (ko) | 락토바실러스 플란타룸 균주를 포함하는 장내 대사산물 조성의 개선을 위한 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211201 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20211201 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20221019 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221206 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230303 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230428 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230602 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230905 |